Targeting PFKFB3 to restore glucose metabolism in acute pancreatitis via nanovesicle delivery.
Journal:
Molecular medicine (Cambridge, Mass.)
Published Date:
Jul 5, 2025
Abstract
BACKGROUND: Acute pancreatitis (AP) is a severe inflammatory disease frequently accompanied by disturbances in glucose metabolism, which further complicate the disease prognosis. This study aims to explore the role of PFKFB3, a key glycolytic enzyme, in regulating glucose metabolism in AP and assess the potential of PFKFB3 inhibition via nanovesicle delivery to mitigate metabolic dysfunction.